key: cord-286960-uz34fjyp
authors: Ali, Nurshad
title: Role of vitamin D in preventing of COVID-19 infection, progression and severity
date: 2020-06-20
journal: J Infect Public Health
DOI: 10.1016/j.jiph.2020.06.021
sha: 
doc_id: 286960
cord_uid: uz34fjyp

The outbreak of COVID-19 has created a global public health crisis. Little is known about the protective factors of this infection. Therefore, preventive health measures that can reduce the risk of infection, progression and severity are desperately needed. This review discussed the possible roles of vitamin D in reducing the risk of COVID-19 and other acute respiratory tract infections and severity. Moreover, this study determined the correlation of vitamin D levels with COVID-19 cases and deaths in 20 European countries as of 20 May 2020. A significant negative correlation (p = 0.033) has been observed between mean vitamin D levels and COVID-19 cases per one million population in European countries. However, the correlation of vitamin D with COVID-19 deaths of these countries was not significant. Some retrospective studies demonstrated a correlation between vitamin D status and COVID-19 severity and mortality, while other studies did not find the correlation when confounding variables are adjusted. Several studies demonstrated the role of vitamin D in reducing the risk of acute viral respiratory tract infections and pneumonia. These include direct inhibition with viral replication or with anti-inflammatory or immunomodulatory ways. In the meta-analysis, vitamin D supplementation has been shown as safe and effective against acute respiratory tract infections. Thus, people who are at higher risk of vitamin D deficiency during this global pandemic should consider taking vitamin D supplements to maintain the circulating 25(OH)D in the optimal levels 75-125 nmol/L. In conclusion, there not enough evidence on the association between vitamin D levels and COVID-19 severity and mortality. Therefore, randomized control trials and cohort studies are necessary to test this hypothesis.

Vitamin D is a steroid hormone, produced endogenously with the effect of ultraviolet radiation on the skin or available from exogenous food sources or dietary supplements. Vitamin D insufficiency is a public health problem affecting over a billion people across all life stages worldwide [1] . In the past decade, several studies demonstrated a potential link between vitamin D deficiency and various diseases, including systemic infection [2] [3] [4] . Vitamin D insufficiency affects the immune functions as vitamin D exerts an immunomodulation role [5] , increasing innate immunity by secretion of antiviral peptides [6, 7] , which improves mucosal defenses. In clinical studies, low levels of serum vitamin D were associated with acute respiratory tract infections including epidemic influenza [8] [9] [10] . A recent meta-analysis incorporating data from J o u r n a l P r e -p r o o f 3 eight observational studies reported that subjects with a serum vitamin D concentration <50nmol/l (i.e. <20ng/ml) had a 64% increased risk of community-acquired pneumonia [11] .

Some recent reviews hypothesized that vitamin D insufficiency may compromise respiratory immune function, increasing the risk of COVID-19 severity and mortality [12, 13] . There are also some retrospective studies that determined the correlation of vitamin D levels with COVID-19 severity and mortality [14] [15] [16] [17] [18] [19] [20] [21] [22] The recent outbreak and fast spreading of SARS-CoV-2 are a global health threat with an unstable outcome worldwide. A recent data reported the antiviral effects of vitamin D, which can hinder viral replication directly, and also be effective in an anti-inflammatory and immunomodulatory way [23] . It seems that SARS-CoV-2 primarily uses the immune evasion process during infection, which is followed by hyper reaction and cytokine storm in some patients [24] , as a known pathogenic process of acute respiratory disease syndrome (ARDS) development [25] . SARS-CoV-2 uses angiotensin-converting enzyme 2 as the host receptor to enter into alveolar and intestinal epithelial cells [26] . Subsequent dysregulation of the reninangiotensin system may lead to excess cytokine production resulting in prospective fatal ARDS [25] .

Considering the differences in the severity and fatality of COVID-19 in the globe, it is important to understand the reasons behind it. Improvement of immunity through better nutrition might be a considerable factor. The nutrient such as vitamin D shows significant roles in immune function. 

Some recent reviews demonstrated some pathways by which vitamin D decreases the risk of microbial infections [28] [29] [30] [31] . Vitamin D follows different mechanisms in reducing the risk of viral infection and mortality. To reduce the risk of common cold, vitamin D uses three pathways: physical barrier, cellular natural immunity, and adaptive immunity [32] . A recent review also supported the possible role of vitamin D in decreasing the risk of COVID-19 infections and mortality [12] . These comprise maintaining of cell junctions, and gap junctions, increasing cellular immunity by decreasing the cytokine storm with influence on interferon γ and tumor necrosis factor α [12] and regulating adaptive immunity through inhibiting T helper cell type 1 responses and stimulating of T cells induction [33] . Vitamin D supplementation was also found to enhance CD4+ T cell count in HIV infection [34] .

One of the major manifestations of severe SARS-CoV-2 infection was lymphopenia [35] . In both the mouse models and in human cell lines, vitamin D exerted activity in lung tissue and played protective effects on experimental interstitial pneumonitis [36] . Several in vitro studies J o u r n a l P r e -p r o o f 5 demonstrated that vitamin D plays a significant role in local "respiratory homeostasis" either by stimulating the exhibition of antimicrobial peptides or by directly interfering with the replication of respiratory viruses [37] . Vitamin D insufficiency can, therefore, be involved in ARDS and heart failure [12] and these are the manifestations of severely ill COVID-19 subjects. Therefore, vitamin D deficiency promotes the renin-angiotensin system (RAS), which may lead to chronic cardiovascular disease (CVD) and reduced lung function [38] . People with such comorbidities account for a higher percentage of severe ill cases in COVID-19 [35] . Although, many studies supported the immunomodulatory characteristics of vitamin D and its significant role in the maintenance of immune homeostasis; well-designed randomized controlled trials are required to elucidate the plausible role of vitamin D in protective immune responses against respiratory microbes and in preventing various types of acute respiratory tract infections.

Yet, it is important to fully elucidate the virulence mechanisms of COVID-19, several cellular mechanisms including Papain-like protease (PLpro)-mediated replication, dipeptidyl peptidase-4 receptor (DPP-4/CD26) binding, disruption of M-protein mediated type-1 IFN induction and MDA5 and RIG-I host-recognition evasion have been recognized in the closely-related COVID-MERS virus [39, 40] . Of the above process, human DPP-4/CD26 has been exhibited to connect with the S1 domain of the COVID-19 spike glycoprotein, suggesting that it could also be a salient virulence factor in Covid-19 infection [41] . The expression of the DPP-4/CD26 receptor is reduced significantly in vivo upon the correctness of vitamin D insufficiency [42] . There is also an indication that maintaining of vitamin D may reduce some of the unfavorable downstream immunological sequelae thought to extract poorer clinical outcome in Covid-19 J o u r n a l P r e -p r o o f 6 infection, such as interleukin 6 elevation, delayed interferon-gamma response [37] , and, a negative prognostic marker in subjects with acutely-ill pneumonia [43] , including those having Covid-19.

Some clinical and epidemiological studies support to outline the hypothesis regarding COVID-19 and its relationship with vitamin D status. Recent studies indicated that COVID-19 is associated with the increased generation of pro-inflammatory cytokines, C-reactive protein (CRP), ARDS, pneumonia, and heart failure [44] [45] [46] [47] . In China, chronic fatality rates were 6-10% for people with chronic respiratory tract disease, cardiovascular disease, hypertension, and diabetes [12, 48] . In other studies, serum concentrations of 25(OH)D were inversely associated with pro-inflammatory cytokines, IL-6, increased CRP, and increased risk of pneumonia, ARDS, diabetes and heart failure [11, [49] [50] [51] [52] [53] [54] . In randomized control trials, vitamin D supplementation has been shown to reduce the risk of respiratory diseases [55, 56] . A placebocontrolled trial with 5660 subjects showed that vitamin D supplementation significantly reduces the risk of respiratory tract infections [57] . A review included five clinical studies reported that respiratory tract infections were significantly lower in the vitamin D supplementation group than the control group [58] . Another study included 25 randomized controlled trials, with 10,933 participants in total from 14 different countries indicated the beneficial effects of vitamin D supplementation in reducing the risk of at least one acute respiratory tract infection [59] . (Table 1) were obtained for 20 May 2020 (all countries after peak) from the global coronavirus pandemic data portal at https://www.worldometers.info/coronavirus/ [27].

The data for mean serum vitamin D concentrations of these 20 countries were obtained from a previous publication [60] . In Pearson's correlation coefficient test, a significant correlation (r = -0.477, p = 0.033) was observed between mean concentrations of vitamin D and number of COVID-19 cases/ 1 M population (Table 1 and Figure 1 ). While, the relationship between mean vitamin D concentrations and the number of COVID-19 deaths/ 1M population was not significant (r = -0.357, p = 0.123). In the present analysis, the negative correlation between vitamin D levels and COVID-19 cases is stronger than that (r = -0.444, p = 0.050) observed on 8

April 2018 (most countries before the peak) in a previous analysis [19] . However, the negative correlation of vitamin D with COVID-19 deaths in the present analysis seems to be more insignificant than the previous analysis ( Table 1 ). The number of cases and deaths per million populations varied from country to country at these two time periods. There is a probability that there exists a cause-effect relationship. The underlying differences in the age distribution, population composition, pre-existing medical conditions and variation in medication uses might be potential confounding variables that could affect the correlation.

Up to now, there is a lack of clinical trials and cohort studies in determining the preventing role In Singapore, a small cohort observation study [62] An Indonesian retrospective cohort study included 780 cases reported that older and male cases with pre-existing medical conditions and below-normal vitamin D levels are associated with higher odds of death [22] . In that study, after adjustment of confounders (age, sex and comorbidity), vitamin D status showed a strong relationship with COVID-19 mortality [22] . A retrospective study in the mainland of USA included a large number of cases demonstrated that J o u r n a l P r e -p r o o f 9 Sunlight and vitamin D, with latitude as an indicator, possibly associated with reduced risks for both COVID-19 cases and mortality [21] .

On the other hand, a study used UK Biobank data (2006-2010) for vitamin D status, and ethnicity and correlated with COVID-19 cases [18] ; no significant difference was observed for vitamin D levels with COVID-19 cases after adjustment of potential confounders. However, ethnicity showed a significant association with COVID-19 infection in univariate analysis.

Another study used the same UK Biobank data (2006-2010) for BMI, vitamin D status and ethnicity and noted some interesting observations [15] . The authors did not find any significant difference for mean vitamin D levels between COVID-19 cases and the control group. Vitamin However, in the regression model, the interaction between BMI and vitamin D status did not predict test results in the available dataset.

It is important to note that there are some potential factors that are associated with COVID-19 severity and mortality, such as age, sex, ethnicity, comorbidities and co-infection. A study determined the impact of comorbidities on 1590 COVID-19 patients in China and reported that COVID-19 patients with any comorbidity (hypertension, diabetes) produced poorer clinical outcomes than those without [63] . Another study in South Korea indicated an association of comorbidities with COVID-19 infection and severe clinical courses [64] . A systematic review and meta-analysis demonstrated that age and the underlying disease including hypertension, J o u r n a l P r e -p r o o f cardiovascular disease, and respiratory system disease are possible risk factors for severe COVID-19 patients compared to non-severe patients [65] . Besides comorbidities, co-infections might be another important determinant of severity and mortality in COVID-19 patients. Both bacterial and fungal co-infections have been identified in COVID-19 patients [66] . Currently, there is no clear evidence that people living with HIV are at higher risk of COVID-19 infection.

However, people living with HIV who have a compromised immune system need extra caution to prevent COVID-19 infections. The importance of co-infections in the severity of respiratory diseases has been widely studied; however, they are understudied in the COVID-19 outbreak.

Therefore, more data on co-infections are required to determine their impacts on COVID-19 severity and mortality. infections and severities but have not yet reported their findings. Up to now, there is a small cohort study described above [16] that demonstrated the protective effects of combined vitamin D, Mg and vitamin B12 against clinical deterioration of COVID-19. In a previous meta-analysis, vitamin D supplementation has been shown as safe and effective in preventing acute respiratory tract infections [59] . They also added that subjects who had severe vitamin D deficiency experienced the maximum benefits from the supplementation. The authors also noticed that the J o u r n a l P r e -p r o o f 11 protective role of vitamin D was high in subjects with a baseline serum 25(OH)D levels <25 nmol/L compared to those with serum 25(OH)D concentrations >25 nmol/L [59] . In the same study, subgroup analysis indicated that daily or weekly intake of vitamin D (without additional bolus doses) showed protective effects against acute respiratory tract infection, especially in persons with vitamin D deficiency. D supplementation also found to increase gene expression related to antioxidation (glutathione reductase modifier subunit) [67] . The increased production of glutathione spares the use of vitamin C, which has potential antimicrobial activities [68, 69] , and has been suggested to prevent and treat COVID-19 infection [12] . Up to now, there is limited evidence that supplementation of vitamin D at 20-50 µg/day has any adverse health effects. Indeed, supplementation of vitamin D with doses up to 100 µg/day is safe for adults [70, 71] , and many expert groups now suggest supplementation in older people, although at lower levels than it. A study reported that intake of vitamin D supplement at 100 to 250 µg/day over 6 weeks increases the baseline serum concentration of 25(OH)D from 2 to 3 folds, respectively, without any adverse health effects [72] .

Thus from literature, it is worth to suggest take up to 250 µg/day for a month which is effective to increase the serum levels of 25(OH)D into the optimal range 75-125 nmol/L. The dose can be reduced to 100 µg/day after one month to maintain the circulating concentrations of 25(OH)D [70, 71] . However, future clinical trials may be worth evaluating the potency of different vitamin D dosing plans on acute respiratory tract infections, for example once per week, which can be easier for implementation. The serum response to the given dose is largely varied between the individuals due to differences in demographic and biological variables, such as ethnicity, age, duration of exposure, seasonal variations, body mass index, intake of certain medications, J o u r n a l P r e -p r o o f 12 baseline concentration of vitamin D, genetics and type of vitamin D supplements [73, 74] .

Moreover, heterogeneity of the population as well as the dose of vitamin D needs to be considered during determining the preventing role of vitamin D in COVID-19. To evaluate the impacts of vitamin D supplementation in randomized controlled trials, emphasis should be given on study design based on serum concentration of 25(OH)D rather than administered dose concentration [74] . A recent review also suggested magnesium supplementation with vitamin D supplements as magnesium helps in regulating phosphate and calcium homeostasis [12] . The enzymes involved in vitamin D metabolism seem to need magnesium which plays an important role as a cofactor in enzymatic reactions especially in the kidney and liver [75] .

In the randomized trials and meta-analysis, vitamin D supplementation has been shown to have protective effects against respiratory tract infections; therefore, people who are at higher risk of vitamin D deficiency during this global pandemic should consider taking vitamin D supplements to maintain the circulating 25(OH)D in the optimal levels 75-125 nmol/L. Some retrospective studies demonstrated a correlation between vitamin D and COVID-19 cases and outcomes, while other studies did not find the correlation when confounding variables are adjusted. Yet, there is insufficient evidence on the association between vitamin D levels and COVID-19 severity and mortality. Therefore, randomized controlled trials and large-scale cohort studies are necessary to test this hypothesis.

The author has no conflict of interest to declare. 

The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention

Vitamin D in autoimmunity: molecular mechanisms and therapeutic potential

Influence of vitamin d on islet autoimmunity and beta-cell function in type 1 diabetes

Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions

Modulation of the immune response to respiratory viruses by vitamin D

Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1, 25-dihydroxyvitamin D3

Direct and indirect induction by 1, 25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin β2 innate immune pathway defective in Crohn disease

Epidemic influenza and vitamin D

Cod liver oil, vitamin A toxicity, frequent respiratory infections, and the vitamin D deficiency epidemic

Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey

The association between vitamin D deficiency and community-acquired pneumonia: A meta-analysis of observational studies

Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths

Preventing a covid-19 pandemic

The Possible Role of Vitamin D in Suppressing Cytokine Storm and Associated Mortality in COVID-19 Patients. preprint. Infectious Diseases (except HIV/AIDS)

Vitamin D status, body mass index, ethnicity and COVID-19: Initial analysis of the first-reported UK Biobank COVID-19 positive cases (n 580) compared with negative controls (n 723). preprint. Infectious Diseases (except HIV/AIDS)

Vitamin D deficiency as risk factor for severe COVID-19: a convergence of two pandemics. preprint. Infectious Diseases (except HIV/AIDS)

Vitamin D Level of Mild and Severe Elderly Cases of COVID-19: A Preliminary Report

Vitamin D concentrations and COVID-19 infection in UK Biobank

The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality

Vitamin D Insufficiency is Prevalent in Severe COVID-19. preprint. Infectious Diseases (except HIV/AIDS)

Sunlight and vitamin D in the prevention of coronavirus disease (COVID-19) infection and mortality in the United States. preprint. In Review

Patterns of COVID-19 Mortality and Vitamin D: An Indonesian Study

The interplay between vitamin D and viral infections

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak -an update on the status

COVID-19 and vitamin D-Is there a link and an opportunity for intervention?

Evidence for gastrointestinal infection of SARS-CoV-2

The role of UV radiation and vitamin D in the seasonality and outcomes of infectious disease

Vitamin D status and the host resistance to infections: what it is currently (not) understood

Vitamin D and Influenza-Prevention or Therapy?

A Review of Micronutrients and the Immune System-Working in Harmony to Reduce the Risk of Infection

Self-care for common colds: the pivotal role of vitamin D, vitamin C, zinc, and Echinacea in three main immune interactive clusters (physical barriers, innate and adaptive immunity) involved during an episode of common colds-Practical advice on dosages and on the time to take these nutrients/botanicals in order to prevent or treat common colds

Vitamin D and 1, 25 (OH) 2D regulation of T cells

The potential protective role of vitamin D supplementation on HIV-1 infection

Covid-19 and vitamin D-authors' reply

Pulmonary activation of vitamin D3 and preventive effect against interstitial pneumonia

Vitamin D modulation of innate immune responses to respiratory viral infections. Reviews in medical virology

Chronic vitamin D deficiency induces lung fibrosis through activation of the renin-angiotensin system

Recent aspects on the pathogenesis mechanism, animal models and novel therapeutic interventions for Middle East respiratory syndrome coronavirus infections

Optimisation of Vitamin D Status for Enhanced Immunoprotection Against Covid-19

Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerging microbes & infections

Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: A randomised double-blinded, placebo-control trial

The study of vitamin D administration effect on CRP and Interleukin-6 as prognostic biomarkers of ventilator associated pneumonia

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet

Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19

The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)-China

Serum 25-hydroxyvitamin d levels and C-reactive protein in persons with human immunodeficiency virus infection

Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS)

Vitamin D deficiency is associated with IL-6 levels and monocyte activation in HIV-infected persons

Link between community-acquired pneumonia and vitamin D levels in older patients

Impact of serum 25-hydroxyvitamin D on cardiac prognosis in Chinese patients with heart failure

Vitamin D Supplementation and Prevention of Type 2 Diabetes

Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials

Nonskeletal health effects of vitamin D supplementation: A systematic review on findings from meta-analyses summarizing trial data

Vitamin D and Respiratory Tract Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Vitamin D for prevention of respiratory tract infections: A systematic review and meta-analysis

Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and metaanalysis of individual participant data

Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society

Vitamin D Supplementation Could Possibly Improve Clinical Outcomes of Patients Infected with Coronavirus-2019 (COVID-2019). Available at SSRN 3571484

A cohort study to evaluate the effect of combination Vitamin D, Magnesium and Vitamin B12 (DMB) on progression to severe outcome in older COVID-19 patients. preprint. Infectious Diseases (except HIV/AIDS)

Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea. preprint. Infectious Diseases (except HIV/AIDS)

Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Mechanisms of Action of Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia

Immunomodulatory and Antimicrobial Effects of Vitamin C

The antiviral properties of vitamin C

Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients

Benefit-risk assessment of vitamin D supplementation

The Effect of Various Doses of Oral Vitamin D3 Supplementation on Gut Microbiota in Healthy Adults: A Randomized, Double-blinded, Dose-response Study

Factors Affecting 25-Hydroxyvitamin D Concentration in Response to Vitamin D Supplementation

Editorial-Vitamin D status: a key modulator of innate immunity and natural defense from acute viral respiratory infections

Role of Magnesium in Vitamin D Activation and Function

NA i) In univariate analysis, older and male cases with preexisting medical condition and below normal vitamin D levels were associated with higher odds of death. ii) After adjustment of confounders (age, sex and comorbidity), vitamin D levels showed a strong relationship with COVID-19 mortality.